HBSP (USA)
-
Social Business at Novartis: Arogya Parivar, Teaching Note
Kramer, Mark R.; Porter, Michael E.Teaching Note HBS-719426-EStrategyTeaching note for case 715411.Starting at €0.00
-
Social Business at Novartis: Arogya Parivar
Porter, Michael E.; Kramer, Mark R.; Lane, DavidCase HBS-715411-EStrategyLate in 2013, Novartis CEO Joseph Jimenez was considering how and whether to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India, while expanding access to medicine and health information to millions of Indian villagers.Starting at €8.20
-
The Link Between Competitive Advantage and Corporate Social Responsibility (Spanish version)
Porter, Michael E.; Kramer, Mark R.Article HBS-R0612DStrategyHow should executives think about corporate social responsibility? and Why is it that the billions of dollars invested in social sector institutions haven't begun to solve our basic problems? Both articles have smart, original things to say about how business leaders can make a real difference. A company that aligns its strategy with its CSR to invest in disruptive social sector innovations might change the world.Starting at €8.20